Literature DB >> 2293951

Nasal glioma. Presenting as neonatal respiratory distress. Definition of the tumor mass by MRI.

B Puppala1, H H Mangurten, J McFadden, N Lygizos, J Taxy, E Pellettiere.   

Abstract

Nasal gliomas are benign congenital midline tumors with the potential for intracranial extension. They are most commonly seen in neonates and children but rarely in adults. The treatment of choice is surgical excision. Inadequate primary excision results in a 4 to 10 percent recurrence. Hence, a thorough preoperative evaluation is essential to delineate the exact site and extension of the tumor and to plan the appropriate surgical approach. Computerized tomographic (CT) scans are useful in visualizing bony defects, but are not well suited for soft tissue imaging. Magnetic resonance imaging (MRI) offers superior soft tissue contrast, without ionizing radiation. This is a report of a neonate with unexplained early respiratory distress. On day 5, a soft nasal mass became apparent. CT scans were inconclusive, so MRI scan was used to demonstrate intracranial extension. MRI is superior for imaging brain tissue, so it should be used preferentially to delineate intracranial extension and to help guide the surgical approach.

Entities:  

Mesh:

Year:  1990        PMID: 2293951     DOI: 10.1177/000992289002900108

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  3 in total

Review 1.  Midline Craniofacial Masses in Children.

Authors:  Renae D Van Wyhe; Edward S Chamata; Larry H Hollier
Journal:  Semin Plast Surg       Date:  2016-11       Impact factor: 2.314

2.  A CARE-compliant article: Extranasal glial heterotopia in a female infant: A case report.

Authors:  Weigang Gan; Yu Xiang; Yiping Tang; Xinrong He; Juanjuan Hu; Fengjuan Yang; Shixi Liu; Junming Xian; Juan Meng
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

3.  Intranasal glial heterotopia in a male infant: A case report.

Authors:  Wei Zhang; Lixing Tang; Pengpeng Wang; Wentong Ge; Xin Ni
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.